Steven T. MerrickChief Executive Officer
Mr. Merrick joined the St. Renatus team in September 2009. As the Chief Executive Officer, he oversees all operations to help fund, complete the FDA process, commercialize, and distribute the new drug. Prior to joining St. Renatus, Mr. Merrick served for 15 years in various management positions for Septodont, the world’s leading provider of injectable dental anesthetics. He held the position of Vice President of Global Marketing for The Pain Control Division during his last three years at Septodont. During his tenure, he was involved in the FDA approval process for a variety of local anesthetics including the best-selling branded anesthetic in dentistry, Septocaine.
Mr. Merrick received a B.A. in Marketing from Rider University in Lawrenceville, New Jersey in 1986. Throughout his professional years, Mr. Merrick has involved himself in many business associations, including serving as the Chairman of Exhibits Committee of The Dental Trade Alliance (DTA) from 2007 to 2009. He currently is a member of St. Renatus’ Board of Directors.
Jill M. Shoemaker, M.B.A.Vice President of Investor Relations
Ms. Shoemaker helped launch the company in 2008. She has been the primary contact for seven funding rounds, talking closely with angel investors on a daily basis. Prior to becoming Vice President of Investor Relations, she served as the Director of Finance. Formerly, she was a Financial Advisor with Merrill Lynch. Ms. Shoemaker began her business career with Oak Associates, ltd., a privately held large capital growth investment manager. She has 15 years of security and client relationship management experience. She serves on the Project Smile community board which focuses on helping children in serious need of dental care.
Ms. Shoemaker received a B.A. in fine arts from The College of Wooster and an M.B.A. from Malone University.